Elsevier, the information analytics company specialising in science and health, has announced a new partnership with MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany, to integrate its chemical products into Reaxys, Elsevier's premier chemistry database. Users of Reaxys will be able to access an additional 43,000 MilliporeSigma compounds and chemicals, with data provided directly from the company. The collaboration also means that users will have access to both product availability as well as standard MilliporeSigma pricing for U.S.-based customers.
The integration with MilliporeSigma provides Reaxys users working in pharmaceutical drug discovery, chemical R&D and more, with a number of key benefits including a more efficient, time-saving process which enables users to purchase chemicals and compounds directly from MilliporeSigma. High-quality and reliable data provided by MilliporeSigma, in combination with Reaxys' unparalleled published experimental reaction data, gives users confidence in making right decisions in their research process. Further, the integration means users are able to quickly compare the cost of purchasing a compound against making it internally. This allows a better allocation of budget resources, while also saving Reaxys' users' time, and accelerating their research.
Reaxys contains more than 240 years of unparalleled chemistry content, including 105 million organic, inorganic and organometallic compounds, 42 million chemical reactions, 500 million published experimental facts, 16,000 chemistry related periodicals and six indexing sources for a cross-disciplinary view of chemistry.
Brought to you by Scope e-Knowledge Center, a world-leading provider of Abstracting & Indexing (A&I) Services, Knowledge Modeling Services (Taxonomies, Thesauri and Ontologies), Metadata Enrichment & Entity Extraction Services.
